Lymphoma
iwNHL 2023 Session V: Expanding the CAR platform in NHL
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 15th December 2023
iwNHL 2023 Session IV: Novel therapies in NHL: BTK inhibitors, BTK degraders, and bispecific antibodies
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 1st December 2023
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 17th November 2023
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as…
Date: 3rd November 2023
Classifying frailty and approaching elderly patients with lymphoma
While the treatment landscape of both Hodgkin and non-Hodgkin lymphoma (HL; NHL) has improved in recent years, there are several…
Date: 13th October 2023
Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL
The treatment and management of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains a major unmet need, and in recent…
Date: 23rd August 2023
Lymphoma highlights at EHA 2023: sequencing bispecifics & CAR-T cells, bridging therapy & toxicity management
The treatment landscape of large B-cell lymphoma (LBCL) has transformed in recent years, with novel immunotherapies including bispecific antibodies and…
Date: 16th June 2023
iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought…
Date: 11th May 2023
Insights into the changing role of chemotherapy in lymphoma
Although several novel agents have been implemented in the treatment of Hodgkin and non-Hodgkin lymphoma (HL; NHL), chemotherapy remains the…
Date: 31st March 2023
NHL highlights at ASH 2022: updates in MCL, the role of transplantation, and novel bispecific antibodies
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,…
Date: 2nd February 2023
T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,…
Date: 20th January 2023
iwNHL Session V: novel therapies in NHL – the role of ADCs
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 16th December 2022
